Through ClientSite you can filter variants and download your reports
Analysis of tumors using liquid biopsy
Characteristics:
- NGS panel and analysis software to screen for the study of the main biomarkers of clinical interest in non-small cell lung cancer and other solid tumors.
- Characterization of ctDNA obtained from a liquid biopsy sample.
- SNV, indel, genetic fusion, and CNV detection in a single DNA sample.
- Based on high sensitivity RNA-probe technology with UMI barcoding (unique molecular identifiers).
- Mean coverage: 7300X, with mean coverage after UMI analysis: 2500X.
- The specificity, sensitivity, and repeatability of this kit are >99% and reproducibility is >97%. Coverage (at a read depth >100X) and uniformity of bases covered at >20X is >96%.
- Limit of detection: SNVs, indels and structural variants: 1%; CNVs: gains of 2.9 copies.
Turnaround time (TAT): 12 working days
Ref. S-202212577
Sequencing of whole exonic regions of 13 genes:
- ALK
- BRAF
- EGFR
- ERBB2
- KIT
- KRAS
- MAP2K1
- MET
- NRAS
- PIK3CA
- RB1
- ROS1
- TP53
Capture of 8 fusion genes with all possible rearrangements covered (including intronic regions with breakpoints previously reported in the literature):
- ALK
- EGFR
- ETV6
- NRG1
- NTRK1
- NTRK2
- RET
- ROS1
Sequencing of 7 hotspot regions in the NTRK1 and NTRK3 genes.
Detection of CNVs across the whole genome. Validation of results and detection of copy-neutral LOH through a low-density SNP array spanning the whole genome.
1) Download & fill out
Please cover as many fields as possible in both documents
2) Sample collection
See sample types in the guidelines
3) Pack the sample
Please pack the sample in a way to prevent leakage
4) Send the sample & the request
Please schedule the delivery for Monday–Friday: 8am – 5pm
5) Result: the report
Via: e-mail and/or through the customer portal
Ask us for more information
Liquid Biopsy – Targeted Liquid Biopsy OncoKit
"*" indicates required fields